Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Total 13F shares
-
97,569,996
-
Share change
-
+3,504,058
-
Total reported value
-
$11,099,337,871
-
Put/Call ratio
-
118%
-
Price per share
-
$113.87
-
Number of holders
-
489
-
Value change
-
+$397,513,543
-
Number of buys
-
226
-
Number of sells
-
227
Institutional Holders of RESMED INC - Common Stock (RMD) as of Q4 2018
As of 31 Dec 2018,
RESMED INC - Common Stock (RMD) was held by
489 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
97,569,996 shares.
The largest 10 holders included
Vanguard Group Inc, BlackRock Inc., FMR LLC, Capital World Investors, STATE STREET CORP, BAILLIE GIFFORD & CO, WCM INVESTMENT MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and JPMORGAN CHASE & CO.
This page lists
489
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.